<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2010 Jun. 101 p.&amp;nbsp;(SIGN publication; no. 118).&amp;nbsp; [300 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke. Rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Nov. 48 p. (SIGN publication; no. 64). [168 references]&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Any amendments to the guideline in the interim period will be noted on the &lt;a href=&quot;http://www.sign.ac.uk/new.html&quot; title=&quot;SIGN Web site&quot;&gt;Scottish Intercollegiate Guidelines Network (SIGN) Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="HCPCS: Splint "/><FieldValue Value="ICD9CM: Aphasia  (784.3); Cerebral artery occlusion, unspecified with cerebral infarction  (434.91); Dysarthria  (438.13); Dysarthria  (784.51); Dysphagia, unspecified  (787.20); Occupational therapy  (93.83); Other venous embolism and thrombosis of unspecified site  (453.9); Pressure ulcer, unspecified site  (707.00); Urinary incontinence, unspecified  (788.30)"/><FieldValue Value="MSH: Activities of Daily Living ; Amitriptyline ; Anticoagulants ; Antidepressive Agents ; Antidepressive Agents, Tricyclic ; Aphasia ; Aspirin ; Bandages ; Carbamazepine ; Community Health Services ; Continuity of Patient Care ; Deglutition Disorders ; Depression ; Dysarthria ; Early Ambulation ; Electric Stimulation ; Electric Stimulation Therapy ; Eyeglasses ; Fecal Incontinence ; Gait ; Home Care Services ; Language Therapy ; Long-Term Care ; Mood Disorders ; Muscle Spasticity ; Nutrition Assessment ; Occupational Therapy ; Patient Care Planning ; Patient Care Team ; Patient Education as Topic ; Patient Participation ; Patient Positioning ; Physical Therapy Modalities ; Pressure Ulcer ; Psychology, Clinical ; Referral and Consultation ; Rehabilitation ; Shoulder Pain ; Social Work Department, Hospital ; Speech Therapy ; Splints ; Stockings, Compression ; Stroke ; Thromboembolism ; Thrombolytic Therapy ; Urinary Incontinence ; Venous Thromboembolism ; Vision Screening "/><FieldValue Value="MTH: Activities of Daily Living (activity) ; Affective Disorders ; Amitriptyline ; Anticoagulants ; Antidepressive Agents ; Aspirin ; Assessment: Cognition ; Bandage ; Carbamazepine ; Cerebrovascular accident ; Compression Stockings ; Deglutition Disorders ; Discharge Planning ; Dysarthria ; Electric stimulation technique ; Electric Stimulation Therapy ; Electromyographs ; Emotional disorder ; Eyeglasses ; Fecal Incontinence ; Home Care Services ; lamotrigine ; Language Therapy ; long-term care ; Mental Depression ; Mobility deficit therapy ; Muscle Spasticity ; Nasogastric tube ; Nutrition Assessment ; Occupational therapy regime ; Patient education (procedure) ; Physical therapy ; Positioning patient (procedure) ; Pressure Ulcer ; Rehabilitation therapy ; Shoulder Pain ; Speech assessment ; Speech Therapy ; Splint Device ; Thromboembolism ; Tricyclic Antidepressive Agents ; Urinary Incontinence ; Venous Thromboembolism "/><FieldValue Value="PDQ: acetylsalicyclic acid ; carbamazepine ; cognitive assessment ; dysphagia ; fecal incontinence ; lamotrigine ; physiotherapy ; thromboembolism ; thrombolytic therapy ; urinary incontinence "/><FieldValue Value="SNOMEDCT_US: Activity of daily living  (129025006); Admission to stroke unit  (306803007); Amitriptyline  (372726002); Amitriptyline  (40589005); Ankle/foot orthosis  (462421009); Anticoagulant  (372862008); Anticoagulant  (81839001); Antidepressant  (36236003); Antidepressant  (372720008); Aphasia  (87486003); Aspirin  (387458008); Aspirin  (7947003); Assessment of nutritional status  (1759002); Assessment of nutritional status  (310243009); Balance exerciser  (705200001); Balance exercises  (386293009); Bandage  (63995005); Bowel care management  (385975007); Bowel training management  (385977004); Carbamazepine  (387222003); Carbamazepine  (40820003); Cerebrovascular accident  (230690007); Client participation  (225330006); Community health services  (413294000); Compression stocking  (348681001); Compression stocking  (467848007); Difficulty swallowing  (288939007); Difficulty swallowing  (40739000); Discharge planning  (371754007); Dysarthria  (8011004); Education of caregiver  (427519008); Education of caregiver  (460617003); Electromyograph  (468237009); Eyeglasses  (50121007); Gait  (271705001); Gait  (63448001); Gait training education, guidance, and counseling  (410294001); Home visit planned by healthcare professional  (408382000); Incontinence of feces  (72042002); Lamotrigine  (387562000); Lamotrigine  (96195007); Language assessment remediation and screening procedure  (273558003); Language therapy  (17395000); Mobility deficit therapy  (370867005); Mood disorder  (46206005); Nasogastric tube  (17102003); Occupational therapy  (84478008); Patient education  (311401005); Physical therapy procedure  (91251008); Positioning patient  (229824005); Pressure ulcer  (399912005); Pressure ulcer  (420226006); Pressure ulcer care management  (385914001); Rehabilitation therapy  (52052004); Shoulder pain  (45326000); Spasticity  (221360009); Spasticity  (397790002); Speech therapy  (5154007); Splint  (16650009); Stroke rehabilitation  (2517002); Subluxation of shoulder joint  (263051004); Therapeutic electrical stimulation  (169430000); Therapeutic electrical stimulation  (57942008); Thromboembolic disorder  (13713005); Thromboembolic disorder  (371039008); Thrombolytic therapy  (426347000); Tricyclic antidepressant  (33219003); Tricyclic antidepressant  (373253007); Upper limb exercises  (229109003); Urinary incontinence  (165232002); Urinary incontinence care management  (408979003); Use of pulley apparatus  (60930003); Vision screening  (408760009)"/><FieldValue Value="SPN: ELECTROMYOGRAPH, DIAGNOSTIC ; STOCKING, MEDICAL SUPPORT (FOR GENERAL MEDICAL PURPOSES) ; TUBE, NASOGASTRIC "/><FieldValue Value="UMD: Bandages  (10-274); Electromyographs  (11-474); Exercisers, Balance  (23-745); Eyeglasses  (11-667); Socks/Stockings, Elastic Compression  (13-789); Tubes, Nasogastric  (14-221)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Stroke&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Rehabilitation" /><FieldValue Value="Risk Assessment" /><FieldValue Value="Screening" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Family Practice" /><FieldValue Value="Geriatrics" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Neurology" /><FieldValue Value="Nursing" /><FieldValue Value="Nutrition" /><FieldValue Value="Ophthalmology" /><FieldValue Value="Optometry" /><FieldValue Value="Physical Medicine and Rehabilitation" /><FieldValue Value="Psychiatry" /><FieldValue Value="Psychology" /><FieldValue Value="Speech-Language Pathology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Allied Health Personnel" /><FieldValue Value="Dietitians" /><FieldValue Value="Hospitals" /><FieldValue Value="Nurses" /><FieldValue Value="Occupational Therapists" /><FieldValue Value="Other" /><FieldValue Value="Patients" /><FieldValue Value="Pharmacists" /><FieldValue Value="Physical Therapists" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /><FieldValue Value="Psychologists/Non-physician Behavioral Health Clinicians" /><FieldValue Value="Public Health Departments" /><FieldValue Value="Social Workers" /><FieldValue Value="Speech-Language Pathologists" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To assist individual clinicians, primary care teams and hospital departments to optimize their management of stroke patients&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The focus of the guideline is on general management, rehabilitation, the prevention and management of complications and discharge planning, with an emphasis on the first 12 months after stroke.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Adult patients with stroke&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Organization of services&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Admission to stroke unit &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Admission to general rehabilitation ward &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Use of multidisciplinary care team &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Early active involvement of patient and carer &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Specialist training and education &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Early mobilization &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Therapeutic positioning &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Personal activities of daily living (ADL) training &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Interventions to improve gait, balance, and mobility &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Interventions for upper limb function &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cognitive assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for visual problems and prescription of eyewear &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Referral to speech and language therapy for assessment and management of aphasia and/or dysarthria &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutritional screening and assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dysphagia therapy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of urinary incontinence and application of behavioral therapies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of fecal incontinence and design of a bowel program &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Routine use of splinting for upper limb to reduce spasticity (not recommended) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Electrical stimulation for prevention of shoulder subluxation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Amitriptyline, lamotrigine, or carbamazepine for central post-stroke pain &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Use of overhead pulleys and functional electrical stimulation for prevention of post-stroke shoulder pain (not recommended) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Shoulder strapping and intra-articular steroids for treatment of post-stroke shoulder pain (not recommended) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of disturbance of mood and emotional behavior, including use of antidepressants for depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pressure ulcer prevention &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Aspirin for venous thromboembolism (VTE) prevention &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Above-knee graduated compression stockings (not recommended) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pre-discharge home visits &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Discharge planning and transfer of care &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Specialist therapy-based rehabilitation services in the community &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Coordinated multidisciplinary care in the community &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Provision of information to patients and carers &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Overall physical and functional outcomes (patient improvement or deterioration) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Death &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dependency &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Long-term care in an institution at one year &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hospital admission rates &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Length of hospital stay &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Incidence of complications &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Quality of life &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Mortality &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Systematic Literature Review&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The evidence base for this guideline was synthesised in accordance with Scottish Intercollegiate Guidelines Network (SIGN) methodology. A systematic review of the literature was carried out using an explicit search strategy devised by a SIGN Information Officer. Databases searched include Medline, Embase, CINAHL, PsycINFO, PEDro, and the Cochrane Library. The year range covered was 2002&amp;ndash;2009 with variations depending on topic. Internet searches were carried out on various websites including the United States National Guideline Clearinghouse and the Guidelines International Network database. A complete search narrative, including search strategies and date ranges for each key question, is available on the SIGN website. The main searches were supplemented by material identified by individual members of the development group.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Literature Search for Patients Issues&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;At the start of the guideline development process, a SIGN Information Officer conducted a literature search for qualitative and quantitative studies that addressed patient issues of relevance to early management of patients with stroke. Databases searched include Medline, Embase, CINAHL and PsycINFO, and the results were summarised and presented to the guideline development group.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;1++&lt;/strong&gt;: High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs), or RCTs with a very low risk of bias&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;1+&lt;/strong&gt;: Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;1-&lt;/strong&gt;: Meta-analyses, systematic reviews, or RCTs with a high risk of bias&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2++&lt;/strong&gt;: High quality systematic reviews of case control or cohort studies. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2+&lt;/strong&gt;: Well-conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2-&lt;/strong&gt;: Case control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;3&lt;/strong&gt;: Non-analytic studies, e.g., case reports, case series&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;4&lt;/strong&gt;: Expert opinion&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Once papers have been selected as potential sources of evidence, the methodology used in each study is assessed to ensure its validity. The result of this assessment will affect the level of evidence allocated to the paper, which will in turn influence the grade of recommendation that it supports.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The methodological assessment is based on a number of key questions that focus on those aspects of the study design that research has shown to have a significant influence on the validity of the results reported and conclusions drawn. These key questions differ between study types, and a range of checklists is used to bring a degree of consistency to the assessment process. The Scottish Intercollegiate Guidelines Network (SIGN) has based its assessments on the MERGE (Method for Evaluating Research and Guideline Evidence) checklists developed by the New South Wales Department of Health, which have been subjected to wide consultation and evaluation. These checklists were subjected to detailed evaluation and adaptation to meet SIGN's requirements for a balance between methodological rigor and practicality of use.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The assessment process inevitably involves a degree of subjective judgment. The extent to which a study meets a particular criterion - e.g., an acceptable level of loss to follow up - and, more importantly, the likely impact of this on the reported results from the study will depend on the clinical context. To minimise any potential bias resulting from this, each study must be evaluated independently by at least two group members. Any differences in assessment should then be discussed by the full group. Where differences cannot be resolved, an independent reviewer or an experienced member of SIGN Executive staff will arbitrate to reach an agreed quality assessment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Evidence Tables&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Evidence tables are compiled by SIGN Executive staff based on the quality assessments of individual studies provided by guideline development group members. The tables summarize all the validated studies identified from the systematic literature review relating to each key question. They are presented in a standard format to make it easier to compare results across studies, and will present separately the evidence for each outcome measure used in the published studies. These evidence tables form an essential part of the guideline development record and ensure that the basis of the guideline development group's recommendations is transparent. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;Additional details can be found in the companion document titled &quot;SIGN 50: A Guideline Developers' Handbook.&quot; (Edinburgh [UK]: Scottish Intercollegiate Guidelines Network. [SIGN publication; no. 50]), available from the &lt;a href=&quot;http://www.sign.ac.uk/guidelines/fulltext/50/&quot; title=&quot;SIGN Web site&quot;&gt;SIGN Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Synthesising the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Guideline recommendations are graded to differentiate between those based on strong evidence and those based on weak evidence. This judgment is made on the basis of an (objective) assessment of the design and quality of each study and a (perhaps more subjective) judgment on the consistency, clinical relevance and external validity of the whole body of evidence. The aim is to produce a recommendation that is evidence-based, but which is relevant to the way in which health care is delivered in Scotland and is therefore implementable.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;It is important to emphasise that the grading does not relate to the importance of the recommendation, but to the strength of the supporting evidence and, in particular, to the predictive power of the study designs from which that data was obtained. Thus, the grading assigned to a recommendation indicates to users the likelihood that, if that recommendation is implemented, the predicted outcome will be achieved.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Considered Judgment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;It is rare for the evidence to show clearly and unambiguously what course of action should be recommended for any given question. Consequently, it is not always clear to those who were not involved in the decision making process how guideline developers were able to arrive at their recommendations, given the evidence they had to base them on. In order to address this problem, the Scottish Intercollegiate Guidelines Network (SIGN) has introduced the concept of considered judgment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Under the heading of considered judgment, guideline development groups summarise their view of the total body of evidence covered by each evidence table. This summary view is expected to cover the following aspects:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Quantity, quality, and consistency of evidence &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;External validity (generalisability) of study findings &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Directness of application to the target population for the guideline &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Any evidence of potential harms associated with implementation of a recommendation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical impact (i.e., the extent of the impact on the target patient population, and the resources required by the National Health Service [NHS] in Scotland to treat them in accordance with the recommendation) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Whether, and to what extent, any equality groups may be particularly advantaged or disadvantaged by the recommendations made &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Implementability (i.e., how practical it would be for the NHS in Scotland to implement the recommendation) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;The group is finally asked to summarise its view on all of these issues, both the quality of the evidence and its potential impact, before making a graded recommendation. This summary should be succinct, and taken together with its views of the level of evidence represent the first draft of the text that will appear in the guideline immediately before a graded recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Additional detail about SIGN's process for formulating guideline recommendations is provided in Section 7 of the companion document titled &quot;SIGN 50: A Guideline Developers' Handbook.&quot; (Edinburgh [UK]: Scottish Intercollegiate Guidelines Network. [SIGN publication; no. 50], available from the &lt;a href=&quot;http://www.sign.ac.uk/guidelines/fulltext/50/&quot; title=&quot;SIGN Web site&quot;&gt;SIGN Web site&lt;/a&gt;).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Grades of Recommendation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Note&lt;/strong&gt;: The grade of recommendation relates to the strength of the evidence on which the recommendation is based. It does not reflect the clinical importance of the recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: At least one meta-analysis, systematic review, or randomised controlled trial (RCT) rated as 1++ and directly applicable to the target population; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and demonstrating overall consistency of results&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Extrapolated evidence from studies rated as 1++ or 1+&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Extrapolated evidence from studies rated as 2++&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Evidence level 3 or 4; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Extrapolated evidence from studies rated as 2+&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Good Practice Points&lt;/strong&gt;: Recommended best practice based on the clinical experience of the guideline development group &lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Public Consultation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The draft guideline was available on the Scottish Intercollegiate Guidelines Network (SIGN) website for a month to allow all interested parties to comment. Comments from the public consultation were addressed alongside those of the specialist reviewers.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Specialist Review&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline was also reviewed in draft form by independent expert referees, who were invited to comment primarily on the comprehensiveness and accuracy of interpretation of the evidence base supporting the recommendations in the guideline. The guideline group addresses every comment made by an external reviewer, and must justify any disagreement with the reviewers&amp;rsquo; comments.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;SIGN Editorial Group&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;As a final quality control check, the guideline is reviewed by an Editorial Group including the relevant specialty representatives on SIGN Council to ensure that the specialist reviewers' comments have been addressed adequately and that any risk of bias in the guideline development process as a whole has been minimised.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Patient Involvement&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Further patient and public participation in guideline development was achieved by involving patients, carers and voluntary organisation representatives in the peer review stage of the guideline and specific guidance for lay reviewers was circulated. Members of the SIGN patient network were also invited to comment on the draft guideline section on provision of information.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;&lt;strong&gt;Note from the Scottish Intercollegiate Guidelines Network (SIGN) and National Guideline Clearinghouse (NGC)&lt;/strong&gt;: In addition to these evidence-based recommendations, the guideline development group also identifies points of best clinical practice in the full-text guideline document.&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The grades or recommendations (A&amp;ndash;D) and levels of evidence (1++, 1+, 1-, 2++, 2+, 2-, 3, 4) are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Organisation of Services&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Organisation of Hospital Care&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Stroke patients requiring admission to hospital should be admitted to a stroke unit staffed by a coordinated multidisciplinary team with a special interest in stroke care.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: In exceptional circumstances, when admission to a stroke unit is not possible, rehabilitation should be provided in a generic rehabilitation ward on an individual basis.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Integrated Care Pathway&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: The routine implementation of integrated care pathways for acute stroke management or stroke rehabilitation is not recommended where a well organised multidisciplinary model of care exists.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Multidisciplinary Team Membership&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: The core multidisciplinary team should include appropriate levels of nursing, medical, physiotherapy, occupational therapy, speech and language therapy, and social work staff.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Patient and Carer Involvement&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Patients and carers should have an early active involvement in the rehabilitation process.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Multidisciplinary Team Communication&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Stroke unit teams should conduct at least one formal multidisciplinary meeting per week at which patient problems are identified, rehabilitation goals set, progress monitored and discharge is planned.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Education and Training&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Members of the multidisciplinary stroke team should undertake a continuing programme of specialist training and education.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Management and Prevention Strategies&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;General Rehabilitation Principles&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Early Mobilization&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Stroke patients should be mobilised as early as possible after stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Therapeutic Positioning&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: Patients should be placed in the upright sitting position, if their medical condition allows.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: Hypoxia inducing positions (&lt;em&gt;lying on the left side regardless of affected side or slumped in a chair&lt;/em&gt;) should be avoided.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Activities of Daily Living (ADL) Interventions&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Personal ADL training by an occupational therapist is recommended for patients with stroke in the community.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Personal ADL training by occupational therapists is recommended as part of an inpatient stroke rehabilitation programme.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Gait, Balance and Mobility&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Treadmill Training&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Treadmill training is not recommended as a routine gait training intervention after stroke. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Treadmill training may be considered to improve gait speed in people who are independent in walking at the start of treatment. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Electromyographic (EMG) Biofeedback&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: EMG biofeedback is not recommended as a routine treatment for gait, balance or mobility problems after stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Visual and Auditory Feedback&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Balance platform training with visual feedback is not recommended for the treatment of gait, balance or mobility problems after stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Electrostimulation&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: Functional electrical simulation may be considered as a treatment for drop-foot, where the aim of treatment is the immediate improvement of walking speed and/or efficiency.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Ankle Foot Orthoses (AFO)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: Where the aim of treatment is to have an immediate improvement on walking speed, efficiency or gait pattern or weight bearing during stance, patients should be assessed for suitability for an AFO by an appropriately qualified health professional.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Approach of Intervention&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Physiotherapists should not limit their practice to one 'approach,' but should select interventions according to the individual needs of the patient.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Physical Fitness Training&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Gait-oriented physical fitness training should be offered to all patients assessed as medically stable and functionally safe to participate, when the goal of treatment is to improve functional ambulation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Electromechanical Assisted Gait Training&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Electromechanical assisted gait training may be offered to selected patients where the necessary equipment is already available and healthcare professionals are competent in the use of the equipment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Repetitive Task Training&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Rehabilitation should include repetitive task training, where it is assessed to be safe and acceptable to the patient, when the aim of treatment is to improve gait speed, walking distance, functional ambulation or sit-to-stand-to-sit.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Muscle Strengthening&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Muscle strength training is recommended when the specific aim of treatment is to improve muscle strength.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Intensity of Intervention&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Where considered safe, every opportunity to increase the intensity of therapy for improving gait should be pursued.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Upper Limb Function&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Constraint Induced Movement Therapy&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Constraint induced movement therapy may be considered for carefully selected individuals with at least 10 degrees of finger extension, intact balance and cognition.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Repetitive Task Training&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Repetitive task training is not routinely recommended for improving upper limb function.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Imagery/Mental Practice&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Mental practice may be considered as an adjunct to normal practice to improve upper limb function after stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Splinting&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Splinting is not recommended for improving upper limb function.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Electromechanical Devices&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Electromechanical/robotic devices may be considered to improve arm motor function and motor strength in selected patients where the necessary equipment is already available and healthcare professionals are competent in the use of the equipment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Intensity of Intervention&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Increased intensity of therapy for improving upper limb function in stroke patients is not recommended.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Visual Problems&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: All stroke patients should be screened for visual problems, and referred appropriately.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Low Visual and Ocular Pathologies&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: Healthcare professionals should ensure that patients have and correctly wear their prescribed eye wear.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Communication&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Aphasia&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Aphasic stroke patients should be referred for speech and language therapy. Where the patient is sufficiently well and motivated, a minimum of two hours per week should be provided.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Dysarthria&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Patients with dysarthria should be referred to an appropriate speech and language therapy service for assessment and management.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Nutrition and Swallowing&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Nutritional Screening and Assessment&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Assessment of nutritional risk should be carried out within the first 48 hours with regular reassessment thereafter during the patient's recovery and be recorded prior to discharge.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Assessment of a patient's nutritional risk should include an assessment of their ability to eat independently and a periodic record of their food consumption.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Ongoing monitoring of nutritional status after a stroke should include a combination of the following parameters:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Biochemical measures (i.e., low prealbumin, impaired glucose metabolism) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Swallowing status &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Unintentional weight loss &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Eating assessment and dependence &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutritional intake &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Nutritional Interventions&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: Following nutritional screening, those identified as undernourished, and those at risk of becoming undernourished, should be referred to a dietitian and considered for prescription of oral nutritional supplements as part of their overall nutritional care plan.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Dysphagia Therapy&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Biofeedback&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: All patients who have dysphagia for more than one week should be assessed to determine their suitability for a rehabilitative swallowing therapy programme. Consideration should be given to:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The nature of the underlying swallowing impairment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patient suitability in terms of motivation and cognitive status &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Patients with dysphagia should have an oropharyngeal swallowing rehabilitation programme that includes restorative exercises in addition to compensatory techniques and diet modification.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Continence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Urinary Incontinence&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: All stroke patients should be assessed, investigated and treated for urinary incontinence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: The presence or absence of incontinence of urine should be documented for all patients after a stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Behavioural therapies for incontinence should be trialled on an individual basis after stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Post-Stroke Spasticity&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Splinting&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Routine use of resting splinting of the upper limb to reduce spasticity in the wrist and finger flexors following stroke is not recommended.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Prevention and Treatment of Shoulder Subluxation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Electrical Stimulation&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Electrical stimulation to the supraspinatus and deltoid muscles should be considered as soon as possible after stroke in patients at risk of developing shoulder subluxation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Pain&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Central Post-Stroke Pain&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: In patients with central post-stroke pain unresponsive to standard treatment, and where clinician and patient are aware of potential side effects, amitriptyline (&lt;em&gt;titrated to a dose of 75 mg&lt;/em&gt;) may be considered.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: If amitriptyline is ineffective, or contraindicated, lamotrigine or carbamazepine are alternatives although the high incidence of side effects should be recognised.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Prevention of Post-Stroke Shoulder Pain&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Overhead Pulleys&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Overhead pulleys to prevent shoulder pain are not recommended.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Electrical Stimulation&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Functional electrical stimulation is not recommended as a means of preventing shoulder pain in patients with upper limb weakness post stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Treatment of Post-Stroke Shoulder Pain&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Strapping&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Shoulder strapping to treat post-stroke shoulder pain is not recommended.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Intra-articular Steroid Injections&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: In the absence of inflammatory disorders, intra-articular steroids should not be used for treatment of post-stroke shoulder pain.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Disturbance of Mood and Emotional Behaviour&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Emotional Lability&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Patients with post-stroke emotionalism may be considered for a course of antidepressant medication.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Preventing Post-Stroke Depression&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Routine prescription of antidepressants is not recommended to prevent post-stroke depression.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Offering routine psychological therapies in one-to-one format following a stroke is not recommended to prevent post-stroke depression. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Psychological principles from motivational interviewing and problem solving should be incorporated into education programmes for people who have had a stroke. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Treating Post-Stroke Depression&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Patients with post-stroke depression should be considered for antidepressant treatment, with decisions made on an individual basis. Clinicians should monitor response to treatment, plan regular reviews and should be vigilant to the possible occurrence of unwanted side effects, issues of adherence to medication and the possibility of symptom relapse.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Pressure Ulcer Prevention&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Hospital managers should ensure that nursing expertise, staffing and equipment levels are sufficient to prevent pressure ulcers. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hospitals should have up-to-date policies on risk assessment, pressure ulcer prevention and treatment. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Venous Thromboembolism&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Early Medication Treatment&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Aspirin (&lt;em&gt;300 mg/day&lt;/em&gt;) should be given to all patients with acute ischaemic stroke in the first two weeks following stroke onset to help prevent deep vein thrombosis and pulmonary embolism (&lt;em&gt;provided there are no known contraindications to aspirin therapy&lt;/em&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Graduated Elastic Compression Stockings&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Above-knee graduated elastic compression stockings to reduce the risk of deep vein thrombosis after acute stroke are not recommended.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Transfer from Hospital to Home&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Pre-Discharge&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Pre-Discharge Home Visits&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Pre-discharge home visits should be undertaken for patients who require them.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Early Supported Discharge (ESD) and Post-Discharge Support&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Patients with mild/moderate stroke should be able to access stroke specialist early supported discharge services in addition to conventional organised stroke inpatient services.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: ESD teams should consist of a specialist multidisciplinary group including nursing, medical, physiotherapy, speech and language therapy and occupational therapy staff.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Home Based or Outpatient Rehabilitation?&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Home based or hospital based (&lt;em&gt;outpatient or day hospital)&lt;/em&gt; rehabilitation should be considered for people after stroke.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Longer Term Stroke Rehabilitation in the Community&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Stroke patients in the community should have access to specialist therapy-based rehabilitation services.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Moving On After a Stroke&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Driving After a Stroke&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: If there is doubt about a patient's ability to drive, patients should be referred to the local Disabled Drivers' Assessment Centre (&lt;em&gt;details available from the Driver and Vehicle Licensing Agency [DVLA]&lt;/em&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;General Practitioner (GP) Care&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: If the patient is to be admitted, the GP should communicate with the hospital staff the basis of the diagnosis, the pre-morbid condition of the patient, any relevant social factors and past medical history, including current medication and known allergies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: For successful discharge, the GPs and community staff should receive adequate information from the hospital prior to discharge.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Roles of the Multidisciplinary Team&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Nursing Care&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: Stroke inpatients should be treated 24 hours a day by nurses specializing in stroke and based in a stroke unit.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Physician Care&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Consultants with an interest in stroke, after adequate training and with appropriate continuing professional development, should be available to coordinate every stroke service or unit.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Physiotherapy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: All patients who have difficulties with movement following stroke should have access to a physiotherapist specializing in stroke. Physiotherapy treatment should be based on an assessment of each patient's unique problems.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Speech and Language Therapy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Speech and language therapists should be involved in stroke management at all stages in the recovery process and should liaise closely with all related healthcare professionals, with outside agencies, both statutory and voluntary, with the individual who has had a stroke and with his/her carers.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Occupational Therapy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: All patients who have problems with activities of daily living following stroke should have access to an occupational therapist with specific knowledge and expertise in neurological care. Occupational therapy treatment should be based on an assessment of each patient's unique problems.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Social Work&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: A social worker should be a member of the multidisciplinary team and should have a key role in the discharge planning process.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Clinical Psychology&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Each multidisciplinary stroke team should have access to a clinical psychologist.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Provision of Information&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Information Needs of Patients and Carers&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Stroke patients and their carers should be offered information about stroke and rehabilitation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Information should be available to patients and carers routinely and offered using active information strategies, which include a mixture of education and counseling techniques.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Information should be tailored to the information needs of individual patients and carers, followed up to check understanding and ensure clarity, and repeated as appropriate.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Information should be tailored to the communication needs and visual needs of individual patients and carers. Patients with aphasia should be provided with accessible and easy to read material, be given sufficient time for assimilation and be followed up by health professionals to ensure understanding.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: Information needs should be monitored and information should be provided at appropriate time points during the recovery trajectory, as information needs change over time.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;1++&lt;/strong&gt;: High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs), or RCTs with a very low risk of bias&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;1+&lt;/strong&gt;: Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;1-&lt;/strong&gt;: Meta-analyses, systematic reviews, or RCTs with a high risk of bias&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2++&lt;/strong&gt;: High quality systematic reviews of case control or cohort studies&lt;/p&gt;&#xD;&#xA;&lt;p&gt;High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2+&lt;/strong&gt;: Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2-&lt;/strong&gt;: Case control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;3&lt;/strong&gt;: Non-analytic studies, e.g., case reports, case series&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;4&lt;/strong&gt;: Expert opinion&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grades of Recommendation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Note&lt;/strong&gt;: The grade of recommendation relates to the strength of the evidence on which the recommendation is based. It does not reflect the clinical importance of the recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;: At least one meta-analysis, systematic review, or RCT rated as 1++ and directly applicable to the target population; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and demonstrating overall consistency of results&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt;: A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Extrapolated evidence from studies rated as 1++ or 1+&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;C&lt;/strong&gt;: A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Extrapolated evidence from studies rated as 2++&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;D&lt;/strong&gt;: Evidence level 3 or 4; &lt;em&gt;or&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Extrapolated evidence from studies rated as 2+&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An algorithm for the assessment and management of new onset post-shoulder pain is provided in the original guideline document.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see &quot;Major Recommendations&quot;).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Creating regional/local consensus on the use of a standardised set of assessments when patient-related information is transferred from one centre to another (or the community) may be an important aspect for improving the quality of care of stroke patients. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from clinical trials suggests that early rehabilitation intervention leads to improved physical and functional outcomes. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Most studies reported significantly more adverse events (i.e., side effects) in individuals receiving antidepressants than those receiving placebo. Possible side effects of antidepressant treatment should be explained to patients prior to commencing treatment.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This guideline is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all clinical data available for an individual case and are subject to changes as scientific knowledge and technology advance and patterns of care evolve. These parameters of practice should be considered guidelines only. Adherence to them will not ensure a successful outcome in every case, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results. The ultimate judgment regarding a particular clinical procedure or treatment plan must be made in light of the clinical data presented by the patient and the diagnostic and treatment options available. However, it is advised that significant departures from the national guideline or any local guidelines derived from it should be fully documented in the patient's case notes at the time the relevant decision is taken.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations within this guideline are based on the best clinical evidence. Some recommendations may be for medicines prescribed outwith the marketing authorisation (product licence). This is known as &quot;off label&quot; use. It is not unusual for medicines to be prescribed outwith their product licence and this can be necessary for a variety of reasons.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Generally the unlicensed use of medicines becomes necessary if the clinical need cannot be met by licensed medicines; such use should be supported by appropriate evidence and experience.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Medicines may be prescribed outwith their product licence in the following circumstances:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;For an indication not specified within the marketing authorisation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;For administration via a different route &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;For administration of a different dose &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;'Prescribing medicines outside the recommendations of their marketing authorisation alters (and probably increases) the prescribers' professional responsibility and potential liability. The prescriber should be able to justify and feel competent in using such medicines.'*&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Any practitioner following a Scottish Intercollegiate Guidelines Network (SIGN) recommendation and prescribing a licensed medicine outwith the product licence needs to be aware that they are responsible for this decision, and in the event of adverse outcomes, may be required to justify the actions that they have taken.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Prior to prescribing, the licensing status of a medication should be checked in the current version of the British National Formulary (BNF).&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Guidance on prescribing. In: The British National Formulary No. 59. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2010.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Implementing the Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Section 8 of the original guideline document provides advice on the resource implications associated with implementing the key clinical recommendations, and advice on audit as a tool to aid implementation. Implementation of national clinical guidelines is the responsibility of each National Health Service (NHS) Board and is an essential part of clinical governance. Mechanisms should be in place to review care provided against the guideline recommendations. The reasons for any differences should be assessed and addressed where appropriate. Local arrangements should then be made to implement the national guideline in individual hospitals, units and practices.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Key points to audit are identified in section 8.2.2. of the original guideline document. Key clinical recommendations that should be priortised for implementation are identified in section 2 of the original guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Audit Criteria/Indicators" /><FieldValue Value="Chart Documentation/Checklists/Forms" /><FieldValue Value="Clinical Algorithm" /><FieldValue Value="Quick Reference Guides/Physician Guides" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2010 Jun. 101 p.&amp;nbsp;(SIGN publication; no. 118).&amp;nbsp; [300 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2002 Nov (revised 2010 Jun)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Scottish Executive Health Department&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Guideline Development Group&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Guideline Development Group&lt;/em&gt;: Professor Lorraine Smith, Professor of Nursing, University of Glasgow (&lt;em&gt;Chair&lt;/em&gt;); Dr Mark Barber, NHS Lanarkshire Stroke MCN Lead Clinician, Monklands Hospital, Airdrie; Dr Phil Birschel, Consultant Stroke Physician, Southern General Hospital, Glasgow; Mrs Sheena Borthwick, Speech and Language Therapist, Western General Hospital, Edinburgh; Ms Gill Bowler, Lay Representative, Edinburgh; Miss Michelle Brogan, Speech and Language Therapy Manager, Astley Ainslie Hospital, Edinburgh; Mr John Brown, Lay Representative, North Berwick; Mr Charlie Chung, Clinical Specialist Occupational Therapist (Stroke), Victoria Hospital, Fife; Mr Ronald Collie, Lay Representative, Aberdeen; Dr Kenneth Collins, General Practitioner, Glasgow; Mrs Fiona Coupar, Chief Scientist Office Research Training Fellow, Glasgow Royal Infirmary; Dr David Gillespie, Consultant Clinical Neuropsychologist, Astley Ainslie Hospital, Edinburgh; Dr Niall Hughes, Consultant Physician in Care of the Elderly/Stroke, Wishaw General Hospital; Ms Michele Hilton Boon, Information Officer, SIGN; Dr Roberta James, Programme Manager, SIGN; Dr Sara Joice, Chartered Health Psychologist, Social Dimensions of Health Institute/School of Nursing and Midwifery, University of Dundee; Mr Thomas Jones, Chest, Heart and Stroke Scotland Stroke Liaison Nurse, St John's Hospital, Livingston; Dr Maggie Lawrence, Research Fellow, Glasgow Caledonian University; Dr Christine McAlpine, NHS Greater Glasgow and Clyde Stroke MCN Lead Clinician, Stobhill Hospital, Glasgow; Dr Alex Pollock, Research Fellow, Stroke Programme, Nursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University; Dr Scott Ramsay, Consultant in Stroke, St John's Hospital, Livingston; Miss Lynn Robertson, Lead Physiotherapist, Stroke Rehabilitation, Dumfries and Galloway Hospital; Mrs Alexandra Shearer, Lay Representative, Orkney; Mrs Fiona Smith, Senior Dietitian, Aberdeen Royal Infirmary; Dr Janice Whittick, Consultant Clinical Psychologist, Stratheden Hospital, Fife; Mrs Kathryn Wood, Lead Clinical Pharmacist, Ashludie Hospital, Monifieth&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Declarations of interests were made by all members of the guideline development group. Further details are available from the Scottish Intercollegiate Guidelines Network (SIGN) Executive.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke. Rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Nov. 48 p. (SIGN publication; no. 64). [168 references]&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Any amendments to the guideline in the interim period will be noted on the &lt;a href=&quot;http://www.sign.ac.uk/new.html&quot; title=&quot;SIGN Web site&quot;&gt;Scottish Intercollegiate Guidelines Network (SIGN) Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in portable document format (PDF) from the &lt;a href=&quot;http://www.sign.ac.uk/guidelines/fulltext/118/index.html&quot; title=&quot;SIGN Web site&quot;&gt;Scottish Intercollegiate Guidelines Network (SIGN) Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Quick reference guide: Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning, Scottish Intercollegiate Guidelines Network, 2010. 16 p. Available in portable document format (PDF) from the &lt;a href=&quot;http://www.sign.ac.uk/pdf/qrg118.pdf&quot; title=&quot;SIGN Web site&quot;&gt;Scottish Intercollegiate Guidelines Network (SIGN) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;SIGN 50: A guideline developer's handbook. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network, 2001 Feb. (SIGN publication; no. 50). Electronic copies available from the &lt;a href=&quot;http://www.sign.ac.uk/guidelines/fulltext/50/&quot; title=&quot;SIGN Web site&quot;&gt;SIGN Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Appraising the quality of clinical guidelines. The SIGN guide to the AGREE (Appraisal of Guidelines Research &amp;amp; Evaluation) guideline appraisal instrument. Edinburgh (Scotland): Electronic copies available from the &lt;a href=&quot;http://www.sign.ac.uk/methodology/agreeguide/index.html&quot; title=&quot;SIGN Web site&quot;&gt;SIGN Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Additional resources, including an example discharge/team care plan and care audit forms, are available in the &lt;a href=&quot;http://www.sign.ac.uk/guidelines/fulltext/118/index.html&quot; title=&quot;SIGN Web site&quot;&gt;original guideline document&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This summary was completed by ECRI on February 6, 2002. The information was verified by the guideline developer as of April 9, 2002. This summary was updated by ECRI on April 28, 2003. The updated information was verified by the guideline developer on June 3, 2003. This summary was updated by ECRI Institute on June 22, 2007 following the U.S. Food and Drug Administration (FDA) advisory on heparin sodium injection. This summary was updated by ECRI Institute on November 2, 2007, following the U.S. Food and Drug Administration advisory on Antidepressant drugs. This summary was updated by ECRI Institute on September 13, 2010.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Scottish Intercollegiate Guidelines Network (SIGN) guidelines are subject to copyright; however, SIGN encourages the downloading and use of its guidelines for the purposes of implementation, education, and audit.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Users wishing to use, reproduce, or republish SIGN material for commercial purposes must seek prior approval for reproduction in any medium. To do this, please contact &lt;a href=&quot;mailto:sara.twaddle@nhs.net&quot;&gt;sara.twaddle@nhs.net&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Additional copyright information is available on the &lt;a href=&quot;http://www.sign.ac.uk/guidelines/published/copyright.html&quot; title=&quot;SIGN Web site&quot;&gt;SIGN Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
